FOLIQ
All guides

Pattern hair loss, explained

The most common cause of thinning in men and women: what DHT does to follicles, how it looks, and why starting early matters.

9 min readLast updatedNovember 10, 2026Next reviewMay 10, 2027

How common it is

Pattern hair loss is the most common reason hair gets thinner over the years. Doctors call it androgenetic alopecia. In men, about half are affected by age 50, and about 80% by age 70 and over.1

It is common in women too, although it looks different and people talk about it less. In two studies of women in the UK and the USA, it affected 3–6% of those under 30, rising to between 3 and 4 in 10 at age 70 and over.1

So if you are noticing it, you are far from alone. It is not caused by anything you did, such as washing too often or wearing a hat.

What is happening in the follicle

Each hair grows in cycles: a long growing phase, a short changing phase and a resting phase. At the end, the hair falls and the follicle starts a new one. If this is new to you, The hair cycle, explained covers it in a few minutes.

Pattern hair loss changes that cycle. The key player is dihydrotestosterone, or DHT. The body makes it from testosterone with the help of an enzyme called 5-alpha reductase. Everyone has DHT, women included. What differs is how sensitive your follicles are to it, and that sensitivity is largely inherited.

In sensitive follicles, DHT shortens the growing phase. Each time the cycle starts again, the follicle comes back a little smaller. Doctors call this miniaturisation. A smaller follicle makes a thinner, shorter and paler hair. Over many cycles, thick hairs are replaced by fine ones that barely cover the scalp.

Two more things follow. Because hairs grow for less time, a bigger share of them is resting at any moment. And the pause between one hair falling and the next one appearing can get longer, so some follicles sit empty for a while.

Fig. 1 An illustration, not measured data: with pattern hair loss, fewer hairs grow at full thickness, and many grow back thin.1 figure = 1 hair

This is why pattern hair loss feels different from shedding. You may not see more hair in the drain. Instead, the hair you have covers less, and the scalp shows through under bright light.

The sensitive follicles sit mostly on the top and front of the head. Follicles at the back and sides are usually spared. That is why even advanced pattern loss tends to leave a band of hair around the back and sides.

How it looks in men and in women

Men

In men, the hairline usually moves back at the temples first, which makes an M shape. Thinning often starts at the crown as well. Over years, the two areas can grow and meet.

Doctors describe these stages with the Hamilton–Norwood scale.2,3 It runs from stage I, with little or no change, to stage VII, where only a band of hair is left at the back and sides. It is a picture scale for describing the pattern. It is not a test, and it does not tell you how fast your own hair will change.

Women

In women, the front hairline usually stays where it is. Instead, hair thins over the top of the head, and the parting slowly gets wider. Many women first notice more scalp under bright light, or a thinner ponytail.

It can begin from the late twenties and is most common after 50.4 Doctors use picture scales for women too, such as the Ludwig scale, which grades how far the parting has widened. Like the scale for men, these scales describe what is there. They do not diagnose anything.

Is it pattern loss or something else?

Pattern hair loss is gradual, over months and years. Sudden heavy shedding all over the head is more likely to be telogen effluvium, which often follows an illness, a birth or a hard time. See Shedding after stress, illness or birth.

Round smooth patches, a sore or red scalp, or hair that breaks off point to other causes. A doctor or dermatologist can usually tell these apart by looking closely at your scalp.

If you are a woman with irregular periods, bad acne or extra facial or body hair, mention it. These can be signs of raised male hormones, and that changes which treatments fit.1

Why starting early matters

Pattern hair loss does not usually stop by itself. In the large finasteride trials, men who took a placebo kept losing hair over two years.5

The general understanding in dermatology is that treatments work on follicles that are still alive and producing hair, even if that hair is thin. A treatment can slow the shrinking, and it can sometimes help a miniaturised follicle grow a thicker hair again. A follicle that has stopped making hair altogether, where the scalp has been smooth and shiny for years, is much less likely to respond. No medicine can make new follicles.

The evidence points the same way. The 2017 European guideline recommends minoxidil and finasteride for men at early to middle stages of the Hamilton–Norwood scale, II to V.1 In the EU, finasteride 1 mg is authorised for men aged 18 to 41 with early-stage pattern hair loss.6 We know much less about how well treatments work at later stages.

So the honest message is not "hurry or lose everything". It is this: if you have noticed thinning and it bothers you, look at your options now rather than in a few years. Keeping hair is easier than getting it back.

The main options

These are the treatments people ask about most. The last column sums up, in plain words, how sure the 2017 European guideline and the best reviews let us be. For a side-by-side view on the same measures, see the pattern hair loss comparison.

OptionWhat it isHow sure we can beMore
MinoxidilLotion or foam on the scalpGood, for women and menGuide
FinasterideDaily 1 mg tablet that lowers DHTGood, for menGuide
Red light (low-level laser)Cap, helmet or comb used at homeSome, as an add-onGuide
Finasteride sprayFinasteride put on the scalpSome: one large trial in menGuide
MicroneedlingFine needles, usually with minoxidilSome, but studies vary a lotGuide
PRPInjections made from your own bloodLittleCompare

Minoxidil is recommended for both women and men by the 2017 European guideline.1 It is sold without a prescription in many European countries, for example Poland and Czechia.7,8 It can cause scalp itching or irritation, and some extra shedding in the first weeks.9,1

Finasteride lowers DHT, so it acts on the cause described above. The guideline recommends finasteride 1 mg for men.1 It needs a prescription, for example in Poland and Ireland.7,10 In 2025 the European Medicines Agency confirmed suicidal thoughts as a side effect of finasteride tablets, with unknown frequency. Anyone on it who notices mood changes should stop and get medical advice.6

Red light devices (low-level laser) shine red light on the scalp. The guideline suggests them as an add-on to other treatment, for both women and men.1

Microneedling uses a roller or pen with fine needles, usually together with minoxidil. Pooled trials found higher hair counts than with minoxidil alone, but results varied a lot between studies, and mild side effects were more common.11 The guideline says more studies are needed.1

PRP (platelet-rich plasma) means injecting a concentrate made from your own blood into the scalp, usually at a clinic. A pooled analysis found more hair than with placebo, but the authors rated the evidence as low quality.12 The guideline makes no recommendation for or against it.1

Hair transplant moves follicles from the back of the head to thin areas. The guideline says it can be considered when there is enough donor hair.1

Two rules apply to almost everything here. First, give a treatment about 6 months before you judge it.1 Second, the effect lasts only while you keep using it. After stopping minoxidil, for example, extra hair loss usually starts about 3 months later.1

For women: what is different

Our guide to hair loss in women covers shedding after birth, iron, thyroid and PCOS too. Here is the short version for pattern hair loss.

The cause in women is less clear than in men. DHT plays a part for many, but many women with pattern hair loss have normal hormone levels. Some treatments that work in men do not carry over.

Minoxidil is the main treatment. A Cochrane review of trials in women found that those using minoxidil were nearly twice as likely as those on placebo to report moderate or marked regrowth.13 The 2% and 5% strengths did about the same.13 The guideline recommends 2% solution twice a day or 5% foam once a day.1

Red light devices have also been tested in women, and the guideline suggests them as an add-on for both sexes.1

Finasteride is a different story. In the same Cochrane review, finasteride 1 mg did no better than placebo in women, although the evidence was weak.13 The guideline suggests not using it after menopause.1 It must not be used by women who are or could become pregnant.

Spironolactone is a tablet that blocks the effect of male hormones. Some doctors prescribe it for women, but the evidence is early. In a small pilot trial, 48 premenopausal women used minoxidil together with either spironolactone or a placebo for 24 weeks.14 More women on spironolactone improved moderately or markedly (38% against 9%). But the difference in hair counts was not clear, and over a third had irregular periods.14

The guideline makes no recommendation for or against spironolactone in women with normal hormone levels, and the Cochrane review lists it among treatments that need more trials.1,13 It is not used in pregnancy, so a doctor will talk about contraception before you start.

What to do first

  • Get it confirmed. A doctor or dermatologist can check that this is pattern hair loss and not another cause. This matters most if your loss is sudden, patchy or comes with other symptoms.
  • Take photos. Photograph your hairline, crown or parting in the same light every month or two. It is the fairest way to judge slow change.
  • Pick something you can keep doing. Every option here works only while you use it. A treatment you can live with for years beats a stronger one you stop after a month.
  • Judge it at 6 months, not 6 weeks. Early shedding on minoxidil is expected, and real change takes time.1

Sources

Numbered in the order the guide first cites them.

  1. 1

    The 2017 European guideline recommends topical minoxidil for women and men and finasteride 1 mg for men, suggests low-level laser as an add-on, makes no recommendation on PRP, and advises judging results at 6 months. Its own expiry date was June 2020, and we found no newer version.

    Kanti V, Messenger A, Dobos G, et al. (2017). S3 – European Dermatology Forum Guideline for the Treatment of Androgenetic Alopecia in Women and in Men. European Dermatology Forum, S3 guideline (literature to Oct 2015, expiry 06/2020)

  2. 2

    Hamilton's original description of the types of patterned hair loss in men; we cite it only as the origin of the Hamilton–Norwood scale.

    Hamilton JB (1951). Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 1951;53(3):708–728

    Partly checked: we could read the record but not every number.

  3. 3

    Classified the pattern of hair loss in 1000 white adult men; the source of the stages used in the Hamilton–Norwood scale.

    Norwood OT (1975). Male pattern baldness: classification and incidence. South Med J 1975;68(11):1359–1365

    Partly checked: we could read the record but not every number.

  4. 4

    In 1006 women aged 20 and over, female pattern hair loss was common from the late twenties and most common after age 50.

    Norwood OT (2001). Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 2001;27(1):53–54

    Partly checked: we could read the record but not every number.

  5. 5

    In 1553 men, finasteride 1 mg gave about 107 more hairs than placebo at 1 year and 138 more at 2 years in a 5.1 cm² crown area, while hair loss kept getting worse on placebo.

    Kaufman KD, Olsen EA, Whiting D, et al. (1998). Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39(4 Pt 1):578–589

  6. 6

    The EU regulator confirmed suicidal thoughts as a side effect of finasteride tablets with unknown frequency, added a patient card to 1 mg packs, found no link for finasteride skin spray, and judged that benefits still outweigh risks.

    European Medicines Agency (2025). Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines. EMA/142716/2025, 8 May 2025

  7. 7

    Poland's medicines register lists finasteride 1 mg tablets as prescription-only and minoxidil 2% and 5% solutions as available without a prescription.

    Rejestr Produktów Leczniczych (Poland) (2026). Register entries for finasteride 1 mg tablets and minoxidil 2% and 5% solutions. Polish medicinal products register, availability category, checked 5 Nov 2026

  8. 8

    Czechia's medicines register lists minoxidil 2% and 5% solutions as available without a prescription; we did not find an oral finasteride 1 mg entry there.

    SÚKL (Czechia) (2026). Register entries for minoxidil 20 mg/ml and 50 mg/ml solutions. SÚKL medicines database, dispensing mode, checked 5 Nov 2026

    Partly checked: we could read the record but not every number.

  9. 9

    In 393 men over 48 weeks, minoxidil 5% gave 45% more regrowth than 2%, with more scalp itching and irritation.

    Olsen EA, Dunlap FE, Funicella T, et al. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002;47(3):377–385

  10. 10

    Ireland's regulator lists finasteride 1 mg tablets as prescription-only and supplied through pharmacies only.

    HPRA (Ireland) (2026). Finasteride 1 mg film-coated tablets: authorised medicine details. Health Products Regulatory Authority, PA22753/002/001, checked 5 Nov 2026

  11. 11

    Pooling 12 trials with 631 patients, microneedling plus minoxidil raised hair counts more than minoxidil alone, but results varied widely and side effects, mostly mild, were more common.

    Ahmed KMA, Kozaa YA, Abuawwad MT, et al. (2025). Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis. Arch Dermatol Res 2025;317(1):528

  12. 12

    Pooling 14 trials with 431 patients, PRP added about 28 hairs/cm² over placebo, but the authors rate the evidence as low quality and highly inconsistent.

    Kieling L, Konzen AT, Zanella RK, et al. (2024). Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis of randomized clinical trials. An Bras Dermatol 2024;99(6):847–862

  13. 13

    Across trials in women, minoxidil nearly doubled the chance of moderate or marked regrowth compared with placebo, 2% and 5% did about the same, and finasteride 1 mg did no better than placebo.

    van Zuuren EJ, Fedorowicz Z, Schoones J (2016). Interventions for female pattern hair loss. Cochrane Database Syst Rev 2016;(5):CD007628

  14. 14

    In a 24-week pilot in 48 premenopausal women also using minoxidil, spironolactone 100 mg did not clearly raise hair counts, though more improved moderately or markedly (38% against 9%) and 37.5% had irregular periods.

    Werachattawatchai P, Khunkhet S, Harnchoowong S, et al. (2025). Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study. Int J Womens Dermatol 2025;11(3):e227

What changed

Last updated
November 10, 2026
Next review
May 10, 2027

First published. No changes since.